Medigene to present first pre-clinical data for MDG1015
Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology platform company focusing on the...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Kathrin Mutze. Real-time updates on events, politics, business and more.